Bacteriology Hub Zagazig University · Medical Microbiology & Immunology · 2013
Systematic Bacteriology · Master Reference Table

Bacteriology at a glance

Compiled verbatim from Basics in Medical Microbiology and Immunology — Part III, Systematic Bacteriology & Mycology (Zagazig University, Faculty of Medicine, Medical Microbiology & Immunology Department, 2013). No external content added. Em dash (—) indicates a column not addressed by the textbook for that organism.

CategoryOrganismBiochemical ReactionsAntigenic StructureVirulence FactorsDiagnosisTreatmentSpecial Characteristic
1 · GPCStaphylococci S. aureus
S. epidermidis
S. saprophyticusGP cocci in irregular grape-like clusters; non-motile, non-sporing; usually non-capsulated
  • Catalase + (differentiates from Strep)
  • S. aureus: coagulase +, DNase +, catalase +, ferments mannitol, gelatin liquefaction +
  • Blood agar: β-hemolysis, yellow/clear zones
  • Nutrient agar: golden yellow colonies (endopigment), best at RT
  • Mannitol salt agar (7.5% NaCl): yellow colonies; selective
  • CoNS: coagulase −; S. saprophyticus novobiocin-resistant; S. epidermidis novobiocin-sensitive
S. aureus cell-wall components
  • Peptidoglycan: elicits IL-1, opsonic Abs; PMN chemoattractant; endotoxin-like; activates complement
  • Teichoic acids: antigenic; part of phage receptors
  • Protein A: binds Fc of IgG except IgG₃; Fab free → "coagglutination" reagent
  • Capsule (some strains): polysaccharide, antiphagocytic unless specific Abs present
  • Phage surface receptors: phage typing
  • Fibronectin-binding proteins (FnBPs): adhesion/invasion
Enzymes
  • Catalase; Coagulase (clots citrated plasma, fibrin coat → resists phagocytosis); Clumping factor (binds fibrinogen non-enzymatically, distinct from coagulase); hyaluronidase, staphylokinase, proteinases, lipases, β-lactamase
Toxins
  • Enterotoxin (A–E, G–I, K–M): superantigen, heat-resistant, acid/enzyme-resistant → food poisoning (vomiting>diarrhea)
  • TSST-1: superantigen → toxic shock (tampons, wound, nasal packing); 5–25% isolates; blood cultures typically negative
  • Exfoliative toxins A & B: proteases dissolving epidermal mucopolysaccharide → SSSS
  • Leukocidins: α (necrosis, hemolysis), β, δ
  • PVL: bicomponent (S+F); severe necrotizing pneumonia in children; CA-MRSA (phage-encoded)
Pigment
  • Staphyloxanthin: carotenoid, antioxidant evading ROS; golden color
  • Specimens by site: blood, pus swab, CSF, urine, vomitus/stool/food
  • Direct smear: GPC in grape-like clusters among pus cells
  • Culture: β-hemolysis blood agar + golden colonies; mannitol salt agar for contaminated samples
  • ID tests: catalase, coagulase, DNase, mannitol fermentation, gelatin liquefaction
  • Phage typing: epidemiologic tracing (hospital outbreaks; food handlers' nose/nailbed/fomites)
  • Routine AST; molecular typing; serology of little value
  • Food poisoning: vomitus/stool/food remnants; mannitol salt agar; demonstrate enterotoxin by gel diffusion
  • ~90% produce β-lactamase → Pen-G resistant; susceptible to β-lactamase-resistant penicillins (methicillin, oxacillin), cephalosporins, vancomycin
  • MRSA (~20%): altered PBPs → DOC vancomycin
  • Newer: linezolid, daptomycin, quinupristin/dalfopristin
  • S. epidermidis: vancomycin + rifampicin or gentamicin
  • Prevention: handwashing, asepsis; intranasal mupirocin for nasal carriage; remove shedders from OR/newborn nurseries
  • ~20% humans are long-term nasal carriers of S. aureus
  • S. epidermidis: most important cause of prosthetic valve endocarditis (biofilm/glycocalyx); CSF shunt infections; neonatal sepsis; peritoneal dialysis peritonitis; hospital-acquired
  • S. saprophyticus: 2nd commonest community UTI in sexually active young women (within 24h post-coitus)
  • CA-MRSA (PVL+) molecularly distinct from HA-MRSA; CA-MRSA: homeless, IVDU, athletes
  • Right-sided (tricuspid) endocarditis in IVDU
  • HA-MRSA causes ~50% of nosocomial S. aureus infections
  • SSSS: young children; recovery 7–10d; hair/nails may slough
  • Staph food poisoning IP 1–8h (preformed toxin in carbohydrate-rich foods, milk products)
1 · GPCStreptococci S. pyogenes (Gp A)
S. agalactiae (Gp B)
Viridans group
S. pneumoniaeGP cocci in chains; oxidase & catalase NEG; facultative anaerobes; many require enriched media
  • Oxidase & catalase negative
  • Hemolysis: β (pyogenes, agalactiae), α (viridans, pneumoniae), γ (bovis)
  • S. pyogenes: bacitracin-sensitive
  • S. agalactiae: CAMP +, hydrolyzes hippurate, NOT bacitracin-sensitive, SXT-resistant, double-zone hemolysis
  • Viridans vs pneumoniae: bile insoluble vs soluble; inulin non-fermenter vs fermenter; optochin resistant vs sensitive; mouse non-pathogenic vs pathogenic; Quellung − vs +
  • Better growth in 5–10% CO₂
S. pyogenes
  • M protein: >150 types; antiphagocytic; rheumatogenic & nephritogenic strains; Abs protective
  • Hyaluronic acid capsule: antiphagocytic, non-immunogenic
  • Lipoteichoic acid: covers pili; mucosal adherence
  • Fibronectin-binding protein: adherence + internalization
  • C-carbohydrate: Lancefield grouping (A–W, no I/J)
S. agalactiae
  • Capsular polysaccharide (classification)
S. pneumoniae
  • ≥90 capsular serotypes; types 1–8 → 75% adult pneumonia; serotyped by Quellung
  • C-polysaccharide (CPS): cell-wall PS common to all pneumococci
S. pyogenes — Enzymes
  • Streptokinase (fibrinolysin) — lyses thrombi; used clinically for MI
  • DNase A–D; anti-DNase B for pyoderma dx
  • Hyaluronidase — "spreading factor"
S. pyogenes — Toxins
  • Pyrogenic exotoxin A (erythrogenic): phage-encoded superantigen → STSS, scarlet fever
  • Pyrogenic exotoxin B: protease → necrotizing fasciitis ("flesh-eating")
  • Pyrogenic exotoxin C → STSS
  • Streptolysin O: O₂-labile, antigenic → ASO titer for RF dx
  • Streptolysin S: O₂-stable, non-antigenic; β-hemolysis on plate
  • C5a peptidase, neuraminidase, serum opacity factor
S. pneumoniae
  • Capsule (antiphagocytic, inhibits C3b opsonization)
  • Pneumolysin (Ply): 53-kDa pore-forming, activates complement
  • Autolysin (LytA): lyses bacteria, releases pneumolysin
  • H₂O₂: damages host cells; bactericidal vs H. influenzae
  • Pili: URT colonization, induce TNF → septic shock
  • CbpA / PspA: adhesin, inhibits complement opsonization
  • Specimens: swabs, pus, blood (bacteremia)
  • Gram stain; Ag detection (ELISA, agglutination)
  • Blood agar, 37°C, 5–10% CO₂; bacitracin disc (GpA); CAMP test (GpB)
  • Latex agglutination for serogrouping
  • Post-strep dz: ASO ≥1/200; CRP (latex w/ anti-CRP); ESR (RF triad ASO+CRP+ESR); anti-DNase B ≥80 U for AGN
  • S. pneumoniae: sheep blood ± gentamicin, 5–10% CO₂; sputum/CSF Gram; PS Ag detection (latex, ELISA); CPS ELISA in sputum; PCR (autolysin, pneumolysin); immune-complex assay; Quellung serotyping (reference labs)
  • S. pyogenes: penicillin DOC; erythromycin if allergic
  • RF prevention: prompt Pen for GAS throat; recurrence prevention with monthly benzathine penicillin for several years
  • S. pneumoniae: penicillin (resistance now prevalent, usually multi-drug); new cephalosporins, fluoroquinolones effective; vancomycin best; routine AST
Pneumococcal vaccines
  • 23-valent polysaccharide: ≥65y, chronic illness 2–64y, immunocompromised; 0.5 mL ID/IM; ≥5y protection
  • 7-valent conjugate: all children at 2, 4, 6 mo + 12–15 mo; selected 24–59 mo
  • Passive Ig for immunodeficient children; chemoprophylaxis for asplenic children
  • M types: rheumatogenic 1, 2, 5, 6, 18; nephritogenic 2, 4, 12, 49, 59–61; impetigo 49, 57, 59–61
  • ARF: 1–4 wk post-throat; anti-M cross-reacts with heart; common, recurrent; long-acting Pen prophylaxis; dx ASO/CRP/ESR; damages valves & myocardium
  • AGN: 3 wk post-skin; Ag-Ab complex on GBM; less common, non-recurrent; dx anti-DNase B; majority recover
  • S. agalactiae: most important cause of neonatal infections; 10–40% females are vaginal carriers; chains appear as paired cocci
  • Viridans (S. mutans): dental caries; SBE on damaged valves via dextran synthesis from glucose adhering to fibrin-platelet aggregates
  • Necrotizing fasciitis: M types 1, 3 + exotoxins A & B (superantigen)
  • S. pneumoniae: lancet-shaped GP diplococci, encapsulated; α-hemolytic
  • Pneumococcal risk: extremes of age, cirrhosis, DM, asplenia (sickle), CSF leak, daycare <2y
  • Scarlet fever: strawberry tongue, sore throat, sunburn rash (host lacks antitoxin)
1 · GPCEnterococci E. faecalis
E. faeciumGP cocci in short chains; formerly Streptococcus (split 1984); >17 species
  • Facultative anaerobes; grow 10–45°C
  • Ordinary media; usually non-hemolytic
  • PYR + and Voges-Proskauer +
  • H₂S production; reduction of litmus milk
  • Grow in 6.5% NaCl broth; bile esculin +
— (textbook does not specify)
  • Gelatinase: protease (gelatin, collagen, peptides)
  • Hemolysin: cytolytic — lyses human, horse, rabbit RBC
  • Biofilm / Enterococcal Surface Protein (ESP): adhesion to bladder epithelium in UTI
  • Extracellular superoxide: enhances E. faecalis survival with B. fragilis
  • Specimens by site: urine, blood, pus
  • Culture: blood agar, MacConkey, CLED (urine), bile esculin, 6.5% NaCl broth
  • Blood culture for bacteremia/endocarditis
  • ID: morphology, Gram, biochem, PYR+, VP+, H₂S, litmus milk reduction
  • Intrinsic + acquired resistance; usually resistant to penicillins & aminoglycosides
  • VRE: major nosocomial pathogen, difficult to treat
  • VRE options: quinupristin/dalfopristin (synercid), linezolid, daptomycin, tigecycline
  • Normal intestinal flora of humans & animals; feared nosocomial pathogens
  • Diseases: UTI, endocarditis, bacteremia, catheter-related, surgical wounds, intra-abdominal & pelvic
  • Infecting strains often originate from patient's own gut flora
  • Genitourinary instrumentation often precedes enterococcal endocarditis
3 · Non-spore GPBCorynebacterium C. diphtheriaeDiphtheroids: C. ulcerans, C. pseudotuberculosis (non-lipophilic); C. jeikeium, C. urealyticum (lipophilic); Propionibacterium acnes (anaerobic)
  • GP rod, clubbed ends, pleomorphic, non-sporing
  • Chinese letter (acute angles) or palisade (parallel)
  • Beaded with methylene blue (metachromatic volutin granules)
  • Aerobic/facultative anaerobic; Loeffler's serum at 37°C
  • Blood tellurite: grey-black; 4 biotypes — gravis, mitis, intermedius, belfanti
  • Oxidase + and catalase +
— (textbook describes only toxin antigenicity)
  • Diphtheria toxin (DT):
    • Gene on lysogenic bacteriophage; non-lysogenized strains = non-pathogenic
    • Production controlled by repressor DtxR (iron-responsive)
    • A-B fragments; B binds receptor; A ADP-ribosylates EF-2 → inhibits protein synthesis
    • C. diphtheriae itself uses a different protein (not EF-2)
    • Heat-labile, highly antigenic; formalin → toxoid (antigenicity retained)
  • Diagnosis is clinical initially — do NOT delay antitoxin
  • Specimen: swab from pseudomembrane / skin lesion
  • Smears: Gram (Chinese letter/palisade); methylene blue (beaded)
  • Culture: Loeffler's serum + blood tellurite
  • Toxigenicity tests (reference labs):
    • Elek's test (immunoprecipitation w/ antitoxin paper)
    • PCR for tox gene
    • ELISA
    • Immunochromatographic assay (rapid, highly sensitive)
    • Tissue culture monolayer overlay
  • Carriers: throat swab
  • Diphtheria antitoxin: 20,000–100,000 U IM/IV after hypersensitivity skin/conjunctival test; only neutralizes circulating toxin
  • Antimicrobials: penicillin or erythromycin — arrest toxin production
  • Supportive care
  • Contacts: DT booster + erythromycin or long-acting Pen; antitoxin NOT indicated
Prevention
  • Diphtheria toxoid (0.3% formalin; adsorbed onto Al(OH)₃ / Al phosphate as adjuvants)
  • DTP/DTaP at 2, 4, 6, 18 mo + school-age booster; adults Td q10y (no pertussis after 6y → encephalopathy)
  • Hexavalent (DTP-HBV-HIB-Polio) available
  • Disease via local + systemic DT effects (organism has little invasive capacity)
  • Pseudomembrane: necrotic epithelium + fibrin + RBC/WBC over tonsils/pharynx/larynx; bleeds if pulled
  • Distant toxic damage: myocarditis (CHF, arrhythmia), nerve paralysis (soft palate, eye muscles, extremities — reversible)
  • IP 2–4d; tonsillar (droplet) commonest; cutaneous (direct contact, fomites) rare
  • C. ulcerans: may carry tox gene → diphtheria-like
  • C. jeikeium: immunocompromised, bacteremia, high mortality, multi-resistant
  • C. urealyticum: urease+, alkaline urine + crystals, slow grower, multi-resistant UTI
  • Propionibacterium acnes: anaerobic, pathogenesis of acne
3 · Non-spore GPBListeria L. monocytogenesShort GP rod, non-sporing; resembles diphtheroids on smear; blends features of Coryne & Strep
  • Catalase + (distinguishes from Strep)
  • Tumbling motility at 22°C, NOT at 37°C
  • Blood agar: small colony with narrow β-hemolysis
  • "Cold enhancement": grows well at refrigeration temperatures
  • Internalin: binds host E-cadherin → endocytic uptake
  • Listeriolysin O (LLO): pore-forming → escapes phagosome to cytosol
  • Bacterial phospholipases (phagosome escape)
  • Actin rockets: actin filament propels bacteria cell-to-cell
  • Immunity primarily cell-mediated
  • Specimens by site: CSF, blood, stool
  • Direct smear: GP rods resembling diphtheroids
  • Culture: small grey colonies + narrow β-hemolysis on blood agar
  • ID: Gram, tumbling motility, catalase +
  • DOC: ampicillin + gentamicin (fulminant cases, T-cell compromise)
  • Alternative: ampicillin + TMP-SMX
  • Resistant strains rare
  • Gastroenteritis: no treatment usually needed
  • Infections primarily in fetus/newborn (transplacental or during delivery) & pregnant women + immunosuppressed (renal transplant, AIDS, lymphoma)
  • Newborn meningitis 1–4 wk post-delivery via bacteremia
  • Primarily an animal pathogen; transmission via contaminated unpasteurized milk/cheese, vegetables, undercooked meats (chicken, hot dogs)
  • Gastroenteritis: watery diarrhea, fever, headache, myalgias, cramps, little vomiting
  • Refrigerator storage of contaminated food increases gastroenteritis risk
2 · Spore-forming GPBBacillus B. anthracis
B. cereusLarge rectangular GP bacilli in long chains; B. anthracis non-motile, capsulated; oval central spores in vitro
  • Aerobic, grow at 37°C
  • B. anthracis nutrient agar: rounded, opaque, grey-white, ground-glass with comma projections — "Medusa head"
  • Blood agar: non-hemolytic
  • Gelatin stab: "inverted fir tree" (longest lateral spikes near surface)
  • B. cereus: β-lactamase producer
  • B. anthracis: unique — only bacterium with a protein capsule (poly-D-glutamic acid); gene on plasmid pXO2; antiphagocytic
B. anthracis — Tripartite exotoxin (pXO1)
  • Edema Factor (EF): A subunit, adenyl cyclase → ↑cAMP → ↓PMN function, massive edema
  • Protective Antigen (PA): receptor binding, channel for EF/LF entry into phagocytes
  • Lethal Factor (LF): protease; with PA = lethal toxin; stimulates macrophage release of TNF-α, IL-1β
  • Both plasmids critical
B. cereus toxins
  • Emetic toxin: heat-stable, reheated rice, IP 1–5h
  • Diarrheal toxin: heat-labile, meat/sauces, IP 8–24h
  • High-risk pathogen: BSC, gloves, mask; chemical fixation (heat does not kill)
  • Specimens: vesicle fluid, exudate, sputum, stools, blood
  • Smears:
    • Gram: large GP rods in chains
    • Polychrome methylene blue (in-vivo capsule): pink rim around blue bacillus → McFadden's reaction
    • Modified ZN (0.5% H₂SO₄): spores stain pink (environmental)
    • IF for rapid dx
  • Culture: Medusa head colonies, non-hemolytic, inverted fir tree; Gram + spore stain
  • Animal inoculation: IP mice/guinea pigs
  • Indirect HA + ELISA for confirmation
  • PCR for bioterrorism
  • B. cereus: stool ≥10⁵/g of incriminated food (usually not done)
  • B. anthracis: ciprofloxacin or doxycycline; early prophylaxis crucial for inhalation
  • B. cereus: resistant to penicillin (β-lactamase); doxycycline, erythromycin, ciprofloxacin
Control/prevention (anthrax)
  • AVA (BioThrax): from avirulent, non-encapsulated strain; adsorbed onto Al(OH)₃; IM deltoid at 0, 4 wks; boost 6, 12, 18 mo; annual
  • Burn/deep-bury carcasses in lime; autoclave animal products; double-bag contaminated materials; live attenuated animal vaccines
  • Anthrax: primarily disease of herbivores (goats, sheep, cows); humans incidental
  • Spores resistant to drying, heat, UV, disinfectants — survive decades in soil
  • Routes:
    • Cutaneous (commonest) → "malignant pustule": painless black eschar with edema rim
    • Pulmonary (wool-sorters' disease): NOT pneumonia — mediastinal hemorrhage + bloody pleural effusion; ~100% lethal
    • GI: rare; vomiting, abdominal pain, bloody diarrhea
  • Spore size 1–2 μm = ideal alveolar penetration → ideal bioterrorism agent
  • B. cereus also opportunistic: post-traumatic endophthalmitis, endocarditis, osteomyelitis, pneumonia
  • B. cereus emetic: nausea, vomiting, ± diarrhea, self-limited 24h; diarrheal: profuse watery, vomiting uncommon
2 · Spore-forming GPBClostridium C. botulinum
C. tetani
C. perfringens
C. difficileNatural habitat: soil & intestinal tract of animals/humans
  • Anaerobes
  • C. tetani: drumstick appearance (terminal spore)
  • C. perfringens: hemolytic anaerobic blood agar; Nagler's reaction (visible precipitate around colonies on egg-yolk media — lecithinase)
  • ID by morphology, sugar fermentation, Nagler's; C. tetani also by gas-liquid chromatography
C. botulinum
  • Botulinum toxin: very potent neurotoxin; blocks ACh release from presynaptic terminals (autonomic + motor end plate) → flaccid paralysis
C. tetani
  • Tetanospasmin: blocks release of inhibitory neurotransmitters (GABA, glycine) → muscle overactivity → tetanic spasm
C. perfringens
  • α-toxin (lecithinase): degrades lecithin → cell lysis
  • θ (theta) toxin: hemolytic, necrotic
  • Proteases, DNases, hyaluronidase, collagenases — liquefy tissue, spread
  • Enterotoxin: heat-labile, produced in meat dishes → hypersecretion in jejunum/ileum
C. difficile
  • Toxin A: enterotoxin → watery diarrhea
  • Toxin B: cytotoxin → pseudomembrane formation
  • C. botulinum:
    • Adult: toxin in leftover food + patient serum by passive HA or RIA
    • Infant: toxin in bowel contents, NOT serum
  • C. tetani: clinical + history; lab generally unhelpful — wound aspirate for GP drumstick bacilli; anaerobic culture + GLC
  • C. perfringens: myonecrosis/cellulitis clinical; deep exudate for large GP rods; anaerobic blood agar (hemolytic, Nagler's reaction)
  • C. difficile: colonoscopy (red mucosa + white pseudomembrane); stool ELISA/latex for toxins A & B
C. botulinum
  • Adult: immediate antitoxin + intubation/ventilation
  • Infant: hospitalization + supportive
C. tetani — 3 patient categories
  • Past immunized, last booster >10y → another booster
  • Never immunized → booster + human TIG
  • Active disease → human TIG + booster + wound cleaning/excision + penicillin + muscle relaxants + respiratory support
C. perfringens
  • Immediate removal of foreign material + devitalized tissue + O₂ exposure
  • Hyperbaric O₂ + penicillin + metronidazole
C. difficile
  • Discontinue initial antibiotic + oral metronidazole or vancomycin
Tetanus prevention
  • Toxoid in DPT at 2, 4, 6, 18 mo; boost 4–6y; boosters q10y
  • Botulism — classic adult: smoked fish, home-canned vegetables → bilateral cranial nerve palsies, diplopia, dysphagia, descending paralysis, respiratory failure
  • Infant botulism: fresh honey → constipation → swallowing difficulty → "floppy baby"
  • Tetanus: spores in soil + horse/animal feces; puncture wound, burn, umbilical stump, surgical sutures; non-invasive; trismus (lockjaw)risus sardonicus → tonic spasm; death from respiratory mechanical failure
  • C. perfringens: gas gangrene — moist spongy cracking skin (gas pockets); clostridial myonecrosis: edematous, foul-smelling, dark, crepitus; clostridial endometritis after incomplete abortion / unsterile instruments
  • C. difficile: 3% general / 30% hospitalized carriers; feco-oral via hospital staff hands; precipitated by fluoroquinolones, macrolides, clindamycin, β-lactam/inhibitor, all cephalosporins; profuse mucoid greenish malodorous watery stools + cramps + fever; onset 5–10 days post-Ab (range 1d to 10 wks after cessation)
9 · GNCNeisseria N. gonorrhoeae (Gonococci)
N. meningitidis (Meningococci)Commensals: N. mucosa, N. sicca, N. flavescens; GN kidney-shaped cocci in pairs, intra-/extracellular in pus; type-IV pili (twitching motility); meningococci capsulated
  • All Neisseria: oxidase + and catalase +
  • N. gonorrhoeae: glucose only (acid)
  • N. meningitidis: glucose + maltose (acid)
  • Commensal Neisseria: variable sugar fermentation
  • Strict aerobe; better in moist atmosphere + 5–10% CO₂ at 37°C × 24h
  • Enriched media: chocolate agar & Modified Thayer-Martin (MTM) — vancomycin + colistin + nystatin + SXT
  • Carbohydrate utilization = principal basis for commercial rapid ID
N. gonorrhoeae
  • Pili (type IV — twitching motility): mucosal attachment
  • Surface proteins: attachment
  • LOS (lipooligosaccharide): highly branched, no repeating O-Ag
  • IgA proteases: cleave secretory IgA
  • Epithelial endocytosis: vacuolar evasion
N. meningitidis
  • Capsular polysaccharide: 13 serogroups; A, B, C, Y, W-135 important; A & C epidemic, B sporadic, A common in Africa; antiphagocytic
  • Outer membrane proteins: class 1, 2, 3 → serotyping; role in internalization
  • Pili (type IV): main adhesion + internalization
  • LPS: endotoxin → septic shock, hemorrhage (RBC destruction)
  • IgA protease
  • (Antigens above act as virulence factors)
  • Gonococcal antigenic heterogeneity + antigenic variation of pili/surface proteins → repeated infections common
  • Gonococcal infection is superficial → IgG poorly protective; secretory IgA destroyed by IgA proteases
Gonorrhea — males acute
  • Urethral discharge; Gram = GN diplococci intra-/extracellular in pus cells (diagnostic)
Chronic males / females (acute & chronic)
  • Specimen: chronic male — morning drop, centrifuged urinary deposit, prostatic fluid post-massage; female — urethral & cervical discharge
  • Gram smear: difficult (flora / low number)
  • Culture: chocolate or MTM at 37°C, 5–10% CO₂; ID by microscopy + biochem; carbohydrate utilization most sensitive
  • Recent: DFA, Gonotest (cross-reactions), DNA probe, ELISA
  • Non-venereal: conjunctival, synovial fluid, blood — same lines
Meningococcal meningitis — CSF
  • Physical: turbid, under tension
  • Cells > 20,000/mm³, PMN predominant
  • Centrifuge → Gram + chocolate agar culture
  • CSF Ag detection: latex agglutination, coagglutination (Staph CoA + anti-meningococcal Ab), counter-IEP, Quellung, DFA
  • Blood culture; PCR for CSF/blood DNA
  • Carriers: West's nasopharyngeal swab → MTM
  • Gonorrhea: ceftriaxone DOC; co-treat for Chlamydia (tetracycline or azithromycin) — 50% co-infection
  • Prevention: condoms; treat partners; erythromycin ointment for ophthalmia neonatorum prevention
  • Meningococcal meningitis: medical emergency — IV penicillin G or ceftriaxone immediately (sometimes pre-LP); 7–10d; chloramphenicol if resistant
  • Chemoprophylaxis (close contacts): rifampicin 600 mg PO BID × 2d OR ciprofloxacin (oral/IM) — secreted in saliva
Meningococcal vaccines
  • MCV4: conjugate (A/C/Y/W-135 + diphtheria toxoid carrier); 2–55y
  • MPSV4: polysaccharide; only one licensed for >55y
  • Group B polysaccharide not included — poorly immunogenic
  • N. meningitidis infects humans only: cannot obtain iron other than from transferrin/lactoferrin
  • Normal nasopharyngeal flora 5–30% adults; up to 70–80% during epidemics
  • Only bacterial meningitis known to occur in epidemics; most common 2–18 y
  • Meningococcemia: high fever, hemorrhagic rash, DIC, collapse
  • Gonococci fragile: susceptible to temperature, drying, UV
  • Female gonorrhea: ~80% asymptomatic; vagina not infected in adults (acidity + flora + stratified squamous); rectal up to 40%
  • Repeated gonococcal infections common (antigenic heterogeneity + pilus/surface variation + superficial → little IgG protection + IgA protease)
  • Ophthalmia neonatorum: cornea → blindness; vulvovaginitis in young females (vagina = simple squamous; via towels/seats)
  • Disseminated gonococcal: hemorrhagic papules/pustules, tenosynovitis/arthritis, endocarditis, meningitis
  • PID → infertility, ectopic pregnancy
4 · EnterobacteriaceaeEscherichia E. coliGN bacilli, usually motile, some capsulated; major facultative bowel anaerobe; family: facultative anaerobes, MacConkey-growing, oxidase NEG, nitrate-reducers, ferment glucose
  • Lactose fermenter — rose-pink on MacConkey
  • Ferments glucose, lactose, maltose, mannitol, sucrose, salicin with acid + gas
  • IMViC: + + − − (indole+, MR+, VP−, citrate−)
  • O (somatic) — cell-wall LPS
  • H (flagellar)
  • K (capsular) in capsulated strains
Diarrheagenic E. coli
  • Pili (colonization factor): epithelial attachment
  • Enterotoxins LT & ST (ETEC): LT A-B → A subunit activates adenylate cyclase → ↑cAMP → Cl secretion + Na inhibition (cholera-like); ST → ↑guanylate cyclase → cGMP → fluid loss
  • Shiga toxin / verotoxin (EHEC, STEC): modifies 28S rRNA → blocks protein synthesis
Uropathogenic E. coli
  • Fimbrial adhesins, hemolysins (exotoxins), K antigen
LPS
  • Endotoxin → endotoxic shock
  • Specimens: feces, urine, wound, respiratory, blood, CSF
  • Direct detection useful only in normally sterile sites (CSF — agglutination for K1 antigen in neonatal meningitis)
  • Culture: MacConkey + blood agar @ 37°C; blood culture for septicemia/meningitis; CLED quantitatively for urine
  • ID: morphology, Gram, oxidase, biochem; slide agglutination with specific antisera; tissue culture for toxin (ETEC, EHEC) / invasiveness (EIEC) / adherence (EPEC, EaggEC); ELISA for toxins; DNA probe or PCR for toxin genes
  • Guide by in-vitro susceptibility (resistant strains emerging)
  • Diarrhea: rehydration + electrolyte correction; selected antibiotics if needed
  • Normal bowel flora — provides colonization resistance; indicator of fecal pollution of water (with E. faecalis, C. perfringens)
  • UTI — most common cause: >80% community; ascending → urethritis, cystitis, pyelitis, pyelonephritis; hospital UTI usually catheter + multi-resistant
  • Neonatal meningitis: E. coli K1 common cause
  • Pneumonia, sepsis, septicemia, endotoxic shock (esp. neonates)
  • Diarrheagenic pathotypes:
    • ETEC: severe diarrhea in infants/children & traveler's diarrhea
    • EHEC / STEC: bloody diarrhea / hemorrhagic colitis; HUS; O157:H7 commonest; ground beef outbreaks; STECs: O26, O111, O103, O121, O45, O145
    • EPEC: infantile diarrhea — tight adherence, interferes with absorption
    • EIEC: Shigella-like, no Shiga toxin
    • EaggEC: persistent diarrhea in children; O104:H4 Germany 2011 (vegetables) — acquired Shiga genes → HUS
4 · EnterobacteriaceaeKlebsiella K. pneumoniae
K. ozaenae
K. rhinoscleromatis
K. oxytocaNon-motile, usually capsulated GN bacilli; environment + intestinal/respiratory mucosa
  • MacConkey: rose-pink, mucoid colonies (slime)
  • Ferments glucose, lactose, maltose, mannitol, sucrose, salicin with acid + gas
  • K. pneumoniae IMViC: − − + +
  • Non-motile
  • 77 serotypes based on capsular polysaccharide
  • Capsule — most important virulence factor
  • Morphology, mucoid colonies, biochem
  • Intrinsically resistant to ampicillin
  • ESBL (extended-spectrum β-lactamase) — resistance to most effective cephalosporins
  • Routine AST required
  • Community & nosocomial:
    • UTI (most common)
    • Lobar pneumonia
    • Wound & bloodstream infections with focal lesions (liver/lung abscess)
    • Neonatal sepsis: septicemia, meningitis
  • K. ozaenaeatrophic rhinitis
  • K. rhinoscleromatisrhinoscleroma (destructive granuloma of nose & pharynx)
  • Multi-drug-resistant nosocomial strains prevail in hospitals
4 · EnterobacteriaceaeCitrobacter, Enterobacter, Serratia Citrobacter
Enterobacter
SerratiaMotile GN bacilli; soil/water/occasionally human respiratory & intestinal tracts
  • Motile lactose fermenters
  • Citrobacter: like E. coli but citrate positive
  • Enterobacter: like Klebsiella but motile
  • Serratia: some strains red non-diffusible pigment — used for testing efficiency of bacterial filters
  • Opportunistic infections similar to K. pneumoniae
4 · EnterobacteriaceaeProteus P. vulgaris
P. mirabilis
Morganella morganii
Providencia rettgeriGN pleomorphic, motile, non-sporing bacilli; soil, sewage, feces
  • Simple & enriched media; concentric wavy "swarming" growth
  • Non-lactose fermenters
  • Urease positive
  • P. vulgaris OX-10, OX-2, OX-K: share antigenic similarity with RickettsiaeWeil-Felix reaction
  • Isolation by morphology, swarming, biochem (urease)
  • According to AST — resistant to many antimicrobials
  • Diseases: UTI, wound infection, otitis media
  • Weil-Felix reaction = key principle for rickettsial serodiagnosis
4 · EnterobacteriaceaeSalmonella S. typhi (Gp D)
S. paratyphi A/B/C
S. typhimurium
S. enteritidis
S. choleraesuisGN bacilli, motile, non-capsulated (S. typhi carriers acquire Vi antigen)
  • MacConkey: pale yellow, NLF
  • Glucose, maltose, mannitol → acid only (S. typhi), acid + gas (S. paratyphi)
  • H₂S + in S. typhi & S. paratyphi B & C
  • Indole − and urease −
  • O (somatic), H (flagellar), Vi (capsular)
  • Pili: host-cell adherence
  • Two pathogenicity islands; contact secretion system
  • Facultative intracellular in macrophages
  • Vi antigen: retards PMN phagocytosis
  • Wk 1: blood + bone marrow culture; Wk 2+: stool + urine culture
  • Serology: Widal — 4-fold rise diagnostic; ≥1/160 in Egypt
  • Carriers: high anti-Vi titer
  • Chloramphenicol, ampicillin, TMP-SMX, FQs, 3rd-gen cephalosporins
  • Carriers: ampicillin, TMP-SMX, ciprofloxacin ± cholecystectomy
  • Enteric fever: endemic Egypt; M cells → Peyer's patches → bacteremia → secondary bacteremia + fever; gallbladder stones favor carriage
  • Food poisoning (S. typhimurium): IP 12–48h; no blood invasion
4 · EnterobacteriaceaeShigella S. dysenteriae (Gp A)
S. flexneri (Gp B)
S. boydii (Gp C)
S. sonnei (Gp D)GN bacilli, non-motile, non-capsulated; strict human pathogens
  • MacConkey/DCA: pale yellow NLF
  • S. sonnei: late lactose fermenter
  • Anaerogenic; H₂S − and urease −
  • Lacks H antigen; 4 serogroups by O antigen
  • Invasiveness: large plasmid; contact secretion system
  • Shiga exotoxin (S. dysenteriae type I): enterotoxic, cytotoxic, neurotoxic
  • Endotoxin (LPS)
  • Stool (blood + mucus); selenite broth → MacConkey/DCA
  • Latex agglutination
  • Fluid & electrolyte replacement
  • Ampicillin, ciprofloxacin, 3rd-gen cephalosporins
  • Infectious dose ~100 organisms; "4 Fs": flies, feces, fingers, food
  • Dysentery triad: cramps, tenesmus, bloody mucoid stools
5 · Non-ferm GNBPseudomonas P. aeruginosaAerobic, non-spore-forming, motile, non-fermentative GN bacilli; ubiquitous in moist hospital environments
  • Non-fermentative; oxidase + and catalase +
  • Grows at 42°C
  • Diffusible exopigments: pyoverdin + pyocyanin → bright green
  • Grape-like odor
  • Pili, flagella; Endotoxin; Biofilm formation
  • Exotoxin A: ADP-ribosylates EF-2 (like DT)
  • Elastase & phospholipase; Exoenzyme S
  • Culture readily; ID by morphology + pigment + biochem
  • Bacteriophage typing for epidemiology
  • Multi-resistant → in-vitro testing required
  • Serious infections: β-lactam + aminoglycoside
  • Community: folliculitis, swimmer's ear, corneal ulcer (contact lens), osteomyelitis (IVDU)
  • Nosocomial: ICU respiratory, UTI, wound, CF chronic lung infection
5 · Non-ferm GNBAcinetobacter A. baumanniiWidely distributed in soil/water; hospital environment
  • GN coccobacilli; oxidase NEGATIVE — differentiates from Neisseria/Moraxella
  • Mistaken for N. meningitidisoxidase NEGATIVE distinguishes
  • Often multi-resistant; susceptibility testing required
  • Nosocomial pneumonia (most common); bacteremia from IV catheters
5 · Non-ferm GNBMoraxella M. catarrhalis
M. lacunata
  • GN bacilli/coccobacilli; non-motile, non-fermentative
  • Oxidase + and DNase +
  • M. catarrhalis: β-lactamase producer
  • Distinguished from Neisseria by DNase positivity
  • Penicillin EXCEPT M. catarrhalis (β-lactamase)
  • M. catarrhalis: otitis media + LRT infection
  • M. lacunata: angular conjunctivitis + blepharitis
6 · Curved GNBVibrios V. cholerae O1 & O139
V. parahaemolyticus
V. vulnificusComma-shaped GN rods; saprophytes in surface water and soil
  • Comma-shaped; single polar flagellum, darting motility
  • Alkaline pH 8.5–9.5; TCBS: V. cholerae yellow; V. parahaemolyticus green
  • Oxidase +, indole +
  • Cholera red reaction +; String test +
  • O1: Ogawa, Inaba, Hikojima; biotypes Classical & El Tor
  • O1 & O139 → epidemic cholera
  • TCP: colonization pilus
  • Cholera toxin (CT): phage-encoded; activates adenylate cyclase → ↑cAMP → massive Cl⁻/Na⁺/water secretion
  • Mucinase
  • Rice-water stools → alkaline peptone water → TCBS
  • Agglutination with anti-O1 and anti-O139 sera; PCR for CT gene
  • IV fluids — most important
  • Tetracycline (shortens excretion)
  • IP 1–4d; rice-water diarrhea; up to 20 L/day fluid loss
  • V. parahaemolyticus: gastroenteritis from seafood; TCBS green
6 · Curved GNBCampylobacter C. jejuni (95%)
C. coli
C. fetusSpiral, motile, GN, microaerophilic
  • Comma-, S-, gull-wing-shaped; microaerophilic + capnophilic
  • Thermophilic — 42°C optimal
  • Skirrow's medium; oxidase + catalase +; urease NEGATIVE
  • Invasiveness; enterotoxin; CDT
  • Stool; Skirrow's at 42°C × 2–4d; 1% basic fuchsin stain
  • Erythromycin or ciprofloxacin (severe)
  • Zoonotic; unpasteurized milk, poultry
  • Complications: Guillain-Barré syndrome, reactive arthritis
6 · Curved GNBHelicobacter H. pyloriMultiple polar SHEATHED flagella
  • Similar to Campylobacter but Skirrow's at 37°C, 1 week
  • Urease POSITIVE — key difference from Campylobacter
  • Urease; Adhesins; VacA; CagA
  • Invasive: rapid urease test, histology, culture
  • Non-invasive: urea breath test, stool ELISA, PCR, serology
  • Triple therapy: metronidazole + bismuth + amoxicillin/tetracycline × 14d
  • Alternative: PPI + amoxicillin + clarithromycin/metronidazole × 1 wk
  • >50% world population colonized
  • Peptic ulcer, chronic gastritis, MALT lymphoma, gastric adenocarcinoma
7 · Fastidious GNBHaemophilus H. influenzae (Hib most pathogenic)
H. ducreyi
H. aegyptius
H. parainfluenzae
  • Need factor X (hemin) + factor V (NAD)chocolate agar
  • Satellite phenomenon around S. aureus
  • Catalase + and oxidase +
  • Types a–f; Hib most pathogenic; most normal-flora strains non-typable
  • IgA protease; PRP capsule (Hib); OMP + LPS
  • Chocolate agar 37°C 5% CO₂; satellite phenomenon
  • Latex agglutination (LAT) for type-b PS in CSF
  • PCR most sensitive
  • Cefotaxime or ceftriaxone
  • Meningitis: steroids 15–20 min before antibiotic
  • H. ducreyi: macrolide + ceftriaxone
  • Hib: meningitis, acute epiglottitis, septic arthritis, cellulitis (5 mo to 5 y)
  • H. ducreyi: chancroid — painful genital ulcer; increases HIV risk
  • H. aegyptius: purulent conjunctivitis + Brazilian purpuric fever
7 · Fastidious GNBBordetella B. pertussis
B. parapertussis
  • Bordet-Gengou or charcoal blood agar; "mercury drop" colonies
  • PT; AC toxin; TCT; FHA + pertactin (adhesion)
  • Saline nasal wash; direct IF; PCR most sensitive
  • Erythromycin DOC
  • DTaP vaccine
  • Phases: catarrhal (infectious) → paroxysmal (whoop + vomiting + cyanosis)
  • Complications: pneumonia, cerebral hemorrhage
7 · Fastidious GNBBrucella Br. melitensis (most virulent)
Br. abortus (needs 8–10% CO₂)
Br. suis
Br. canis
  • GN short coccobacilli; slow growers (blood cultures 1 month)
  • BSC required; catalase + oxidase +; urease +
  • 2 LPS antigens A and M; immunity mainly cell-mediated
  • Facultative intracellular parasite; LPS endotoxic; L antigen
  • Blood cultures (repeated); STAT ≥1/100; prozone avoided by dilutions; Coombs for blocking IgA; ELISA; PCR
  • Tetracycline + (streptomycin OR rifampicin)
  • No human vaccine; pasteurization
  • Undulant fever; endemic Egypt; transmission: intestinal, mucous membranes, skin
  • Localize in reproductive organs → sterility & abortion in animals
7 · Fastidious GNBFrancisella F. tularensis
  • GN coccobacillus; modified Thayer-Martin agar
  • Strict lab precautions (highly infectious)
  • Streptomycin or gentamicin × 10d; live attenuated vaccine for lab workers
  • Reservoir: rabbits, rodents; ticks; tularemia; dangerous bioweapon
8 · Yersinia / PasteurellaYersinia Y. pestis (plague)
Y. enterocolitica
Y. pseudotuberculosis
  • Y. pestis: NLF; bipolar staining; non-motile; better at 27–30°C
  • Y. enterocolitica: urease +, motile at 25°C, non-motile at 37°C; cold enrichment
  • F1 capsular antigen; V-W antigens (virulent strains)
  • LPS; F1 antigen; V-W antigens; YOPs (inhibit phagocytosis); exotoxin
  • Y. pestis: DFA; PCR; culture at 27–30°C; BSC always
  • Y. enterocolitica: cold enrichment → MacConkey at 25°C
  • Y. pestis: ciprofloxacin, doxycycline, gentamicin; formalin-killed vaccine
  • Yersiniosis: doxycycline + aminoglycoside
  • Plague: bubonic/septicemic/pneumonic; rat-flea cycle; bioterrorism agent
  • Y. enterocolitica: children; may mimic appendicitis
8 · Yersinia / PasteurellaPasteurella P. multocida
  • Non-motile GN coccobacilli with bipolar staining; oxidase + catalase +
  • Standard culture from wound discharges
  • Most common organism in cat/dog bites or scratches; cellulitis, osteomyelitis, arthritis
10 · AnaerobesBacteroides B. fragilisPredominant anaerobe in human colon
  • Slim, pale-staining, capsulated GN rods; strict anaerobe
  • Superoxide dismutase; polysaccharide capsule → abscess formation; LPS less toxic; collagenase, fibrinolysin, heparinase
  • Anaerobic culture
  • Drainage + debridement; almost always β-lactamase producers
  • Clindamycin, metronidazole; imipenem; clavulanate/sulbactam combinations
  • Endogenous from patient's own gut; peritonitis + intra-abdominal abscess
  • Spreads to blood more than any other anaerobe
10 · Anaerobes / ActinomycetesActinomycetes Actinomyces israelii (anaerobic)
Nocardia asteroides (aerobic)
Streptomyces
Actinomadura madurae
  • Aerobic species: partially acid-fast, beaded branching filaments
  • Anaerobic species (Actinomyces): GP branching filaments; anaerobic culture × 2 weeks
  • Actinomycosis: sulfur granules; GP branching filaments + radiating GN clubs
  • Nocardia: GP, partially acid fast
  • Actinomycosis: surgical drainage + penicillin G 6–12 mo
  • Nocardiosis: TMP-SMX
  • Actinomycosis: cervicofacial, thoracic, abdominal forms; sulfur granules in pus
  • Nocardiosis: frequently misdiagnosed as TB; brain abscess
  • Mycetoma: swelling + sinuses draining granules; feet of farmers without shoes
11 · Atypical GNBLegionella L. pneumophila
  • Fastidious aerobic GN; poorly stained with Gram; BCYE agar
  • Inhibition of phagosome-lysosome fusion; C3b coating
  • BCYE aerobic; urinary antigen by ELISA (fastest); PCR; serology
  • Macrolides or fluoroquinolones
  • Prevention: hyperchlorination + heating of water supplies
  • No person-to-person spread; aerosols from A/C + shower heads
  • Legionnaire's disease (pneumonia) vs Pontiac fever (mild flu)
11 · Minor pathogensBartonella B. bacilliformis
B. quintana
B. henselae
  • Small GN, polymorphic, motile bacilli
  • B. bacilliformis: penicillin, streptomycin, chloramphenicol
  • B. henselae: supportive ± tetracycline/erythromycin
  • B. bacilliformis: Oroya fever (sand flies)
  • B. quintana: Trench fever (body lice)
  • B. henselae: Cat-scratch disease (2 wk post-scratch)
11 · Minor pathogensGardnerella G. vaginalis
  • Gram variable coccobacilli
  • "Whiff" test (KOH → fishy odor); clue cells; vaginal pH ≥ 4.5
  • Metronidazole DOC
  • Bacterial vaginosis; premature rupture of membranes, preterm labor
12 · MycobacteriaMycobacterium M. tuberculosis + M. bovis (MTC)
M. leprae
Atypicals: MAC, M. kansasii, M. scrofulaceum, M. marinum, M. fortuitum
  • Acid fastness due to mycolic acids
  • M. tb: resists 25% H₂SO₄; M. leprae: 5% H₂SO₄
  • Slow growers; obligate aerobes
  • Lowenstein-Jensen, Middlebrook 7H10/7H9, BACTEC
  • Never reported negative before 8 wks
  • Glycolipids → granuloma formation; intracellular survival
  • No exotoxin, no endotoxin
  • ZN + auramine stain; culture = gold standard; PCR
  • Latent: Mantoux ≥10 mm or IGRA (not affected by BCG)
  • M. leprae: NOT culturable; lepromin test
  • TB: INH + RIF + PZA + EMB/SM × 6–12 mo
  • MDR-TB: resistant ≥ INH + RIF; XDR-TB: MDR + FQ + ≥3 second-line
  • Leprosy: dapsone + rifampicin × 2 years
  • BCG: first year of life; also for bladder carcinoma
  • 1/3 world infected; 90% destroy; 10% active disease
  • Primary (Ghon's) → secondary (reactivation: upper lobes, cavitation, miliary)
  • Lepromatous (leonine facies, lepromin −) vs Tuberculoid (anesthesia, lepromin +)
13 · SpirochetesTreponema T. pallidum
  • Not cultivable; microscopy + serology only
  • Outer membrane proteins (adherence); hyaluronidase
  • Dark-ground microscopy; Silver (Fontana); Direct IF; PCR
  • Non-specific STS: VDRL, RPR; Specific: FTA-ABS, MHA-TP (remain + for life)
  • Penicillin; tetracycline/erythromycin if allergic
  • Primary: nontender chancre (50% serology negative)
  • Secondary: maculopapular rash incl. palms/soles, condylomata lata
  • Tertiary: gummas, aortitis, CNS
  • Congenital: Hutchinson's teeth, saddle nose, interstitial keratitis
13 · SpirochetesBorrelia B. burgdorferi (Lyme)
B. recurrentis (epidemic RF)
B. duttoni (endemic RF)
  • Spirochete morphology
  • Lyme: ELISA + Western immunoblot
  • Relapsing fever: Leishman/Giemsa blood films; mouse inoculation in afebrile phase
  • Tetracyclines and penicillin
  • Lyme: "bull's eye" ECM; myocarditis; arthritis (immune complex)
  • Epidemic RF (lice, B. recurrentis, human reservoir) vs Endemic RF (tick bite)
  • ANUG (Vincent's): polymicrobial, immunocompromise (HIV)
13 · SpirochetesLeptospira L. interrogans
  • Culture on Fletcher's or Stuart's medium at 30°C
  • Blood (during fever), urine (from week 2)
  • Serology: agglutination + ELISA from week 2
  • Penicillin and tetracyclines
  • Reservoir: rats; contact with animal urine in water
  • Weil's disease: jaundice + hemorrhages + renal failure ± meningitis
  • Occupational: sewage workers, farmers, fishermen
14 · MycoplasmaMycoplasma M. pneumoniae
M. hominis
U. urealyticum
M. genitalium
  • No rigid cell wall (sterols in membrane); completely resistant to penicillin
  • Fried-egg colonies ≥1 wk
  • Cold agglutinins: titer >1/128 positive (50%)
  • Serology most useful: IgM or rising IgG (ELISA/CFT); cold agglutinin ≥1/128
  • IF for Ag; PCR/DNA probes
  • Tetracyclines or macrolides
  • M. pneumoniae: atypical pneumonia
  • U. urealyticum: NGU; lung disease in low-birth-weight premature infants
15 · RickettsiaRickettsia & Coxiella Typhus: R. prowazekii, R. typhi, O. tsutsugamushi
Spotted: R. rickettsii, R. akari
Coxiella burnetii
  • Non-motile GN; obligate intracellular
  • Coxiella: endospore-like structure → heat/UV/drying resistant
  • Coxiella: Phase I (infectious, nature) vs Phase II (avirulent)
  • Weil-Felix cross-reactivity with P. vulgaris OX strains
  • Vasculitis via intracellular multiplication in endothelial cells
  • Initial diagnosis clinical — do NOT delay treatment
  • IFA, CF, ELISA; 4-fold rise diagnostic
  • Brill-Zinsser: rapid early IgG (vs IgM in primary typhus)
  • Doxycycline DOC; chloramphenicol
  • Epidemic typhus (lice, human reservoir); centrifugal rash; Brill-Zinsser = latent reactivation
  • Endemic typhus (rat flea); RMSF: centripetal rash (ankles/wrists → trunk/face)
  • Q fever: pneumonia + granulomatous hepatitis, NO rash; chronic → endocarditis
16 · ChlamydiaChlamydiaceae C. trachomatis (A–C, D–K, L1–L3)
C. psittaci
C. pneumoniae
  • Obligate intracellular; 250–400 nm; no peptidoglycan
  • EB (infectious, extracellular) → RB (replicating, intracellular) → EB
  • McCoy cells (trachomatis/psittaci); HEP-2 cells (pneumoniae)
  • Group-specific LPS; strain-specific OMPs; ≥15 serotypes
  • Cytoplasmic inclusion bodies: Giemsa, iodine, fluorescent Ab stain
  • Ag by ELISA or IF; PCR; cell culture with iodine stain for inclusion bodies
  • Tetracycline or erythromycin
  • STD: doxycycline or azithromycin; treat partners
  • C. psittaci: quarantine imported birds
  • A–C: Trachoma (leading preventable infectious blindness)
  • D–K: NGU, PID, inclusion conjunctivitis, neonatal pneumonia
  • L1–L3: LGV → genital elephantiasis
  • C. psittaci: psittacosis (pet parrots), atypical pneumonia
  • C. pneumoniae: atypical pneumonia; possibly associated with atherosclerosis

Source · Zagazig University Faculty of Medicine, Medical Microbiology and Immunology Department, Basics in Medical Microbiology and Immunology, Part III: Systematic Bacteriology & Mycology (2013). All content extracted verbatim from this textbook only.

Abbreviations · GPC Gram-positive cocci · GPB Gram-positive bacilli · GNB Gram-negative bacilli · GNC Gram-negative cocci · DOC drug of choice · IP incubation period · NLF non-lactose fermenter · ZN Ziehl-Neelsen · BSC biosafety cabinet · IFA indirect fluorescent antibody · DFA direct fluorescent antibody · MDR multi-drug resistant · MRSA methicillin-resistant S. aureus · ARF acute rheumatic fever · AGN acute glomerulonephritis · UTI urinary tract infection · PID pelvic inflammatory disease · TB tuberculosis · IGRA interferon-gamma release assay · BCG Bacille Calmette-Guérin · ECM erythema chronicum migrans · NGU non-gonococcal urethritis · LGV lymphogranuloma venereum · MTM modified Thayer-Martin · BCYE buffered charcoal yeast extract · TCBS thiosulfate citrate bile sucrose · CLED cysteine lactose electrolyte deficient · LPS lipopolysaccharide · LOS lipooligosaccharide · CMI cell-mediated immunity · CSF cerebrospinal fluid · HUS hemolytic uremic syndrome · DIC disseminated intravascular coagulation.